Skip to main content
Clinical Trials/NL-OMON40167
NL-OMON40167
Completed
Not Applicable

Intermittent sacral neuromodulation for treatment of idiopathic overactive bladder in women - Intermittent sacral neuromodulation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
16
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- written informed consent
  • \- sufficient knowledge of the Dutch language to understand the informed consent form and to complete the questionnaires
  • \- female at least 18 years of age
  • \- subjective successful treatment for at least 6 months through sacral neuromodulation using InterStim for OAB
  • \- at least three months of anticholinergic treatment without result or had to stop anticholinergic treatment because of adverse side effects before implantation of the neuromodulator
  • \- currently not using anticholinergic or other medical treatment for idiopathic OAB
  • \- last intravesical Botox treatment at least 12 months ago

Exclusion Criteria

  • \- neuropathic bladder
  • \- symptomatic urinary tract infection
  • \- indwelling catheter or clean intermittent catheterization
  • \- implantable neurostimulator of which the estimated service life of the battery is less than 1 year at the moment of inclusion in the study
  • \- radiation therapy of the pelvis
  • \- (previous) bladder cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials